We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Advanced Melanoma

Journal Scan / Review · September 09, 2020

The Role of T-VEC in the Treatment of Melanoma

American journal of clinical dermatology

 

Additional Info

American journal of clinical dermatology
An Update on the Role of Talimogene Laherparepvec (T-VEC) in the Treatment of Melanoma: Best Practices and Future Directions
Am J Clin Dermatol 2020 Aug 07;[EPub Ahead of Print], CA Larocca, NR LeBoeuf, AW Silk, HL Kaufman

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading